World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
17409
World Ranking
3471
National Ranking
1612

Carol J. Landers publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carol J. Landers sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 149 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carol J. Landers D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carol J. Landers sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carol J. Landers is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily focuses on medical sciences, with a particular emphasis on genetics, epidemiology, pulmonary and respiratory medicine, surgery, and immunology.

The scientist has contributed extensively to the understanding of inflammatory bowel disease and related conditions, with a significant number of publications covering topics such as:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Cystic Fibrosis Research Advances
  • Child Nutrition and Feeding Issues
  • Eosinophilic Esophagitis
  • Gut microbiota and health
  • Autoimmune and Inflammatory Disorders

Among their recent scholarly works are several papers published between 2021 and 2024, including:

  • "Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrate overlapping shifts in the colonic mucosal-luminal interface microbiome," 2022, Genome Medicine
  • "Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis," 2023, Gut
  • "Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease," 2021, Diseases of the Colon & Rectum
  • "Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families," 2024, Gut
  • "Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease," 2021, Crohn's & Colitis 360

Carol J. Landers has collaborated frequently with other researchers, notably including:

  • Dermot McGovern
  • Stephan R. Targan
  • Gil Melmed
  • Cian Greaney
  • Christina Ha

The scientist's research has been published in several prominent venues where they have a strong presence, including:

  • Journal of Cystic Fibrosis
  • Gastroenterology
  • Gut
  • The American Journal of Gastroenterology
  • Genome Medicine

Best Publications

  • Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.

    Jason Lloyd-Price;Jason Lloyd-Price;Cesar Arze;Ashwin N. Ananthakrishnan;Melanie Schirmer;Melanie Schirmer

  • Bacterial flagellin is a dominant antigen in Crohn disease

    Michael J. Lodes;Yingzi Cong;Charles O. Elson;Raodoh Mohamath

  • A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

    Andrew Saxon;Fergus Shanahan;Carol Landers;Tomas Ganz

  • Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

    William S. Mow;Eric A. Vasiliauskas;Ying Chao Lin;Phillip R. Fleshner

  • Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

    Stephan R. Targan;Carol J. Landers;Huiying Yang;Michael J. Lodes;Michael J. Lodes

  • Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease

    Maria T. Abreu;Kent D. Taylor;Jerome I. Rotter;Huiying Yang

  • Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.

    Carol J. Landers;Offer Cohavy;Rajeev Misra;Huiying Yang

  • Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models.

    Jose J. Limon;Jie Tang;Dalin Li;Andrea J. Wolf

  • Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

    Eric A. Vasiliauskas;Scott E. Plevy;Carol J. Landers;Scott W. Binder

  • Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: Comparison with other colitides/ diarrheal illnesses

    Richard H. Duerr;Richard H. Duerr;Stephan R. Targan;Stephan R. Targan;Carol J. Landers;Carol J. Landers;Lloyd R. Sutherland;Lloyd R. Sutherland

  • A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

    Stephan R Targan;Brian Feagan;Severine Vermeire;Remo Panaccione

  • Genetic markers may predict disease behavior in patients with ulcerative colitis.

    Maria Roussomoustakaki;Jack Satsangi;Ken Welsh;Edouard Louis

  • Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.

    Ian D R Arnott;Carol J Landers;Elaine J Nimmo;Hazel E Drummond

  • Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn’s Disease: Immune Responses Predict Disease Progression

    Marla C. Dubinsky;Ying Chao Lin;Debra Dutridge;Yoana Picornell

  • TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

    Hidetoshi Takedatsu;Kathrin S. Michelsen;Bo Wei;Carol J. Landers

  • ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.

    Kent D. Taylor;Huiying Yang;Carol J. Landers;Jerome I. Rotter

  • Increased immune reactivity predicts aggressive complicating Crohn's disease in children.

    Marla C. Dubinsky;Subra Kugathasan;Ling Mei;Yoana Picornell

  • High-Titer Antineutrophil Cytoplasmic Antibodies in Type-1 Autoimmune Hepatitis

    Stephan R. Targan;Carol Landers;Alda Vidrich;Albert J. Czaja

  • Identification of a novel bacterial sequence associated with Crohn's disease

    Christopher L. Sutton;Jeong Kim;Akemi Yamane;Harnisha Dalwadi

  • Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.

    Fergus Shanahan;Fergus Shanahan;Richard H. Duerr;Richard H. Duerr;Jerome I. Rotter;Jerome I. Rotter;Huiying Yang;Huiying Yang

Frequent Co-Authors

Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
Dermot P.B. McGovern
Dermot P.B. McGovern Cedars-Sinai Medical Center
Jerome I. Rotter
Jerome I. Rotter UCLA Medical Center
Marla Dubinsky
Marla Dubinsky Icahn School of Medicine at Mount Sinai
Kent D. Taylor
Kent D. Taylor David Geffen School of Medicine at UCLA
Jonathan Braun
Jonathan Braun Cedars-Sinai Medical Center
Talin Haritunians
Talin Haritunians Cedars-Sinai Medical Center
Charles O. Elson
Charles O. Elson University of Alabama at Birmingham
Maria T. Abreu
Maria T. Abreu University of Miami
Subra Kugathasan
Subra Kugathasan Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open diverse career opportunities. Many students consider advancing into healthcare roles, where understanding immune responses directly benefits patient care. Programs like cheap psych np programs offer affordable pathways into specialized nursing roles, making it easier to combine immunology knowledge with mental health expertise.

Nurses interested in leadership and advanced clinical roles often explore the Doctor of Nursing Practice (DNP). Understanding the doctor of nursing practice salary by state helps prospective students choose programs that align with their financial and professional goals.

Transitioning between nursing roles is another important consideration. For example, acnp programs support nurses moving from Family Nurse Practitioner (FNP) roles to Acute Care Nurse Practitioner positions, expanding their clinical expertise, often directly informed by immunology knowledge when managing complex patients.

For those eager to fast-track their education, accelerated np program options provide a focused, efficient path to becoming a nurse practitioner. These programs help integrate immunology insights into advanced nursing practice quickly.

Best Scientists Citing Carol J. Landers

Trending Scientists

Recently Published Articles